Biotech · Private company
Corxel Pharmaceuticals
Track this companyFree. Adds Corxel Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials53 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- JX10Phase 3 · Acute Ischemic StrokeClinicalTrials.gov · fetched Nov 12, 2026
- CX11Phase 2 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
- CX11Phase 2 · Type II Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- CX11Phase 1 · Obesity & OverweightClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 TabletsPHASE1 · RECRUITING · started May 11, 2026ClinicalTrials.gov NCT07652047 · fetched Nov 12, 2026
- A Study of CX11 Tablets in Patients With Type 2 Diabetes MellitusPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 6, 2026ClinicalTrials.gov NCT07340320 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese ParticipantsPHASE2 · COMPLETED · started Jun 17, 2025ClinicalTrials.gov NCT07011797 · fetched Nov 12, 2026
- Optimizing Reperfusion to Improve Outcomes and Neurologic FunctionPHASE2_PHASE3 · RECRUITING · started May 15, 2025ClinicalTrials.gov NCT06990867 · fetched Nov 12, 2026
- Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCMPHASE3 · COMPLETED · started Feb 1, 2022ClinicalTrials.gov NCT05186818 · fetched Nov 12, 2026